Goldman Sachs Maintains Neutral on RXO, Lowers Price Target to $21
RXO, Inc. Common Stock
RXO, Inc. Common Stock RXO | 0.00 |
Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE:
RXO) with a Neutral and lowers the price target from $24 to $21.
